UK Markets open in 17 mins

OTCMKTS : OCEL

EQS-News: Organicell Regenerative Medicine, Inc.
OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷
22.11.2022 / 17:33 CET/CEST
The issuer is solely responsible for the content of this announcement.

Contact Details

Organicell Investor Relations

IR@organicell.com

Company Website

https://organicell.com/


News Source: News Direct


22.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:

English

Company:

Organicell Regenerative Medicine, Inc.

United States

ISIN:

US68621D1072

EQS News ID:

1494035


 

End of News

EQS News Service

show this
show this